About Ron Mazumder
Form D filings for Actym Therapeutics in 2023 list Ron Mazumder as director.
Ron Mazumder first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ron Mazumder in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ron Mazumder works with at each company, as listed on that company's latest Form D.
Actym Therapeutics, Inc. · Form D, Jul 6, 2023
CT
Christopher Thanos
Chief Executive Officer and director
BC
Benjamin Chen
Director
JC
Julie Cherrington
Director
KD
Kanad Das
Director